In 2006, 2 rotavirus vaccines were licensed. We summarize the impact of rotavirus
vaccination on hospitalizations and deaths from rotavirus and all-cause acute gastroenteritis …

Background Since 2006, more than 100 countries have introduced rotavirus vaccine into
their immunization programs. We reviewed published data on relative reductions of rotavirus …

Background As new rotavirus vaccines are being introduced in immunization programs,
global and national estimates of disease burden, especially rotavirus-associated mortality …

Importance Rotavirus infection is the global leading cause of diarrhea-associated morbidity
and mortality among children younger than 5 years. Objectives To examine the extent of …

Vaccines are now available to combat rotavirus, the most common cause of severe diarrhea
among children worldwide. We review clinical trial data for available rotavirus vaccines and …

Background WHO recommends routine use of rotavirus vaccines in all countries, particularly
in those with high mortality attributable to diarrhoeal diseases. To establish the burden of life …

Background. Routine rotavirus vaccination of US infants began in 2006. We conducted
active, population-based surveillance for rotavirus gastroenteritis hospitalizations in 3 US …

Background: Rotavirus is the leading cause of vaccine-preventable diarrhea among children
under 5 globally. Rotavirus vaccination has been shown to prevent severe rotavirus …

Background: Rotavirus vaccine was recommended for routine use in US infants in 2006.
Before the introduction of vaccine, rotavirus was the most common cause of severe …

Recently a new rotavirus vaccine was licensed in the United States and recommended for
universal immunization of American children. The impact of the vaccine on a decrease in …